Literature DB >> 1530174

Epidural clonidine enhances postoperative analgesia from a combined low-dose epidural bupivacaine and morphine regimen.

T Mogensen1, K Eliasen, E Ejlersen, P Vegger, I K Nielsen, H Kehlet.   

Abstract

In a randomized, double-blind, placebo-controlled trial, the value of adding clonidine to a low-dose epidural regimen for postoperative pain treatment was assessed. Twenty-four patients scheduled for hysterectomy during combined thoracic epidural (bupivacaine and morphine) and general anesthesia were studied. Postoperative analgesia consisted of epidural bupivacaine (5 mg/h) and morphine (0.1 mg/h) for 12 h. In addition, the patients randomly received clonidine (75 micrograms), followed by an infusion of 18.75 micrograms/h or saline solution (placebo) epidurally. Pain was evaluated at rest, during cough, and during mobilization every hour. Sensory level of analgesia was evaluated by pinprick. We found no significant difference in pain scores at rest between the clonidine and placebo groups but an enhanced analgesic effect by clonidine during cough and mobilization (P less than 0.05). Arterial blood pressure decreased significantly during clonidine infusion and remained lower than in the control group throughout the study. We conclude that a continuous low-dose epidural clonidine infusion enhances analgesia from a combined low-dose epidural bupivacaine and morphine regimen after hysterectomy; however, the concomitant decrease in arterial blood pressure during epidural clonidine deserves further study before such a regimen can be recommended.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530174     DOI: 10.1213/00000539-199210000-00025

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

1.  The role of clonidine and alpha 2-agonists for postoperative analgesia.

Authors:  A N Sandler
Journal:  Can J Anaesth       Date:  1996-12       Impact factor: 5.063

2.  A Double-Blind Randomized Controlled Trial Comparing Epidural Clonidine vs Bupivacaine for Pain Control During and After Lower Abdominal Surgery.

Authors:  Alaa A Abd-Elsayed; Maged Guirguis; Mark S DeWood; Sherif S Zaky
Journal:  Ochsner J       Date:  2015

3.  Evaluation of Efficacy of Epidural Clonidine with 0.5% Bupivacaine for Postoperative Analgesia for Orthopaedic Lower Limb Surgeries.

Authors:  Karthik Krishnamoorthy; Saravanan Ravi; Ilango Ganesan
Journal:  J Clin Diagn Res       Date:  2015-09-01

4.  [Spinal administration of alpha 2-adrenoceptor agonists and opioids or local anaesthetic agents].

Authors:  J Motsch
Journal:  Schmerz       Date:  1996-02-15       Impact factor: 1.107

5.  [Alpha 2-adrenoceptor agonists for the treatment of chronic pain].

Authors:  P J Kulka
Journal:  Schmerz       Date:  1996-04-25       Impact factor: 1.107

6.  Adjuvants to local anesthetics: A combination wisdom.

Authors:  Manpreet Kaur
Journal:  Anesth Essays Res       Date:  2010 Jul-Dec

7.  Comparative Study of Clonidine with Ropivacaine versus Ropivacaine Alone in Epidural Anesthesia for Lower Limb Orthopedic Surgery.

Authors:  Mahendra Singh; Amitesh Pathak; Aamir Laique Khan; Amit Srivastava; Devendra Negi
Journal:  Anesth Essays Res       Date:  2017 Oct-Dec

Review 8.  A Systematic Review and Meta-Analysis of Intraperitoneal Bupivacaine in Laparoscopic Gynecologic Surgery.

Authors:  Greg Marchand; Kelly Ware; Malini Govindan; Ahmed T Masoud; Alexa King; Stacy Ruther; Giovanna Brazil; Kaitlynne Cieminski; Nicolas Calteux; Catherine Coriell; Hollie Ulibarri; Julia Parise; Amanda Arroyo; Diana Chen; Maria Pierson; Rasa Rafie; Katelyn Sainz
Journal:  J Pain Res       Date:  2021-09-02       Impact factor: 3.133

9.  An observational study to evaluate the effect of different epidural analgesia regimens on dynamic pain scores in patients receiving epidural analgesia for postoperative pain relief after elective gynecological surgery.

Authors:  Manpreet Singh; Ranju Singh; Aruna Jain
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.